Dysregulated Selectin Expression and Monocyte Recruitment During Ischemia-Related Vascular Remodeling in Diabetes Mellitus

Objective—Diabetes mellitus (DM) is associated with impaired ischemia-related vascular remodeling and also dysregulation of the inflammatory response. We sought to determine whether impaired selectin-mediated monocyte recruitment in ischemic tissues contributes to blunted ischemia-mediated angiogenesis in DM. Methods and Results—Contrast-enhanced ultrasound perfusion imaging and molecular imaging of endothelial P-selectin expression in the proximal hindlimb were performed at 1, 3, and 21 days after arterial ligation in wild-type and db/db mice. Ligation reduced muscle blood flow to ≈0.05 mL/minute per gram in both strains. Significant recovery of flow occurred only in wild-type mice (60%–65% of baseline flow). On molecular imaging, baseline P-selectin signal was 4-fold higher in db/db compared with wild-type mice (P<0.01) but increased minimally at day 1 after ischemia, whereas signal increased approximately 10-fold in wild-type mice (P<0.01). Immunohistology of the hindlimb skeletal muscle demonstrated severely reduced monocyte recruitment in db/db mice compared with wild-type mice. Local treatment with monocyte chemotactic protein-1 corrected the deficits in postischemic P-selectin expression and monocyte recruitment in db/db mice and led to greater recovery in blood flow. Conclusion—In DM, there is dysregulation of the selectin response to limb ischemia, which leads to impaired monocyte recruitment, which may be mechanistically related to reduced vascular remodeling in limb ischemia.

[1]  K. Matrougui,et al.  Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice , 2010, Laboratory Investigation.

[2]  L. Messina,et al.  Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. , 2009, Journal of vascular surgery.

[3]  J. Waltenberger,et al.  Diabetes Mellitus Activates Signal Transduction Pathways Resulting in Vascular Endothelial Growth Factor Resistance of Human Monocytes , 2009, Circulation.

[4]  D. Link,et al.  Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein‐1‐dependent fashion , 2008, Journal of leukocyte biology.

[5]  E. Barrett,et al.  Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. , 2007, American journal of physiology. Endocrinology and metabolism.

[6]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[7]  Aleksander S. Popel,et al.  Impaired Angiogenesis After Hindlimb Ischemia in Type 2 Diabetes Mellitus: Differential Regulation of Vascular Endothelial Growth Factor Receptor 1 and Soluble Vascular Endothelial Growth Factor Receptor 1 , 2007, Circulation research.

[8]  M. Fujimoto,et al.  Endothelial selectins regulate skin wound healing in cooperation with L‐selectin and ICAM‐1 , 2007, Journal of leukocyte biology.

[9]  J. Lindner,et al.  Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. , 2007, European heart journal.

[10]  J. Lindner,et al.  Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.

[11]  B. Annex,et al.  In Mice With Type 2 Diabetes, a Vascular Endothelial Growth Factor (VEGF)-Activating Transcription Factor Modulates VEGF Signaling and Induces Therapeutic Angiogenesis After Hindlimb Ischemia , 2007, Diabetes.

[12]  C. Emanueli,et al.  Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia. , 2007, Frontiers in bioscience : a journal and virtual library.

[13]  T. Matsuishi,et al.  Ischemia‐induced angiogenesis: role of inflammatory response mediated by P‐selectin , 2006, Journal of leukocyte biology.

[14]  M. Voskuil,et al.  Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice , 2004, Vascular medicine.

[15]  S. Soker,et al.  VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis. , 2004, Blood.

[16]  W. Schaper,et al.  Collateral Artery Growth (Arteriogenesis) After Experimental Arterial Occlusion Is Impaired in Mice Lacking CC-Chemokine Receptor-2 , 2004, Circulation research.

[17]  J. Phillips,et al.  Single Injection of P-Selectin or P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Blocks Neointima Formation After Arterial Injury in Apolipoprotein E-Deficient Mice , 2003, Circulation.

[18]  D. Sane,et al.  Abnormal angiogenesis in diabetes mellitus , 2003, Medicinal research reviews.

[19]  H. Thorlacius,et al.  CC chemokines induce P‐selectin‐dependent neutrophil rolling and recruitment in vivo: intermediary role of mast cells , 2003, British journal of pharmacology.

[20]  S. Kaul,et al.  Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. , 2002, American journal of physiology. Endocrinology and metabolism.

[21]  K. Ley,et al.  Ultrasound Assessment of Inflammation and Renal Tissue Injury With Microbubbles Targeted to P-Selectin , 2001, Circulation.

[22]  B. Nieswandt,et al.  Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. , 2000, Blood.

[23]  J. Waltenberger,et al.  Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. , 2000, Circulation.

[24]  S. Kaul,et al.  Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. , 1999, The American journal of physiology.

[25]  A. Abacı,et al.  Effect of diabetes mellitus on formation of coronary collateral vessels. , 1999, Circulation.

[26]  R. Hynes,et al.  Angiogenesis in P‐ and E‐Selectin‐Deficient Mice , 1998, Microcirculation.

[27]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[28]  W. Schaper,et al.  Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. , 1998, The Journal of clinical investigation.

[29]  W. Schaper,et al.  Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. , 1997, Circulation research.

[30]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[31]  A. Rose,et al.  Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material , 1992, The Journal of pathology.